Job description
We are seeking a Patient & Community Educator (PACE) to deliver compliant, non-promotional education to caregivers, patients, residential staff, and healthcare professionals on Prader-Willi syndrome (PWS) and Soleno’s approved therapy.
Company
Healthcare
Soleno Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, with a particular focus on Prader-Willi syndrome. In March 2025, the company secured FDA approval for its first and only treatment targeting hyperphagia in PWS, marking a significant milestone in addressing a critical unmet medical need. Leveraging a rigorous scientific approach alongside strong advocacy and community engagement, Soleno blends cutting-edge research with patient-centric values to deliver impactful solutions. The organization fosters a collaborative culture that empowers scientists, clinicians, and patients to work together toward transformative health outcomes.